Recent studies have investigated EV protein biomarker dynamics in NSCLC and reported that an increase in PD-L1 in EV following treatment with ICIs is associated with poor response and survival outcomes [166]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.